Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant LAG3 anticorps

L’anticorps Rat Monoclonal anti-LAG3 a été validé pour IP, FACS et BP. Il convient pour détecter LAG3 dans des échantillons de Souris.
N° du produit ABIN7072736

Aperçu rapide pour Recombinant LAG3 anticorps (ABIN7072736)

Antigène

Voir toutes LAG3 Anticorps
LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 107
  • 38
  • 9
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Souris

Hôte

  • 56
  • 48
  • 11
  • 4
  • 2
  • 1
Rat

Clonalité

  • 66
  • 53
  • 2
Monoclonal

Conjugué

  • 64
  • 9
  • 6
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp LAG3 est non-conjugé

Application

  • 73
  • 41
  • 37
  • 37
  • 28
  • 24
  • 15
  • 13
  • 13
  • 11
  • 10
  • 9
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunoprecipitation (IP), Flow Cytometry (FACS), Blocking Peptide (BP)

Clone

C9B7W
  • Fonction

    Anti-LAG-3 [C9B7W], Rat IgG1, kappa

    Specificité

    This antibody is specific for an epitope in the D2 domain of murine LAG-3.

    Attributs du produit

    Original Species of Ab: Rat

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogène

    This antibody was raised by immunising Lewis rats with a murine LAG-3:Ig fusion protein.

    Isotype

    IgG1 kappa
  • Indications d'application

    This antibody has been used in flow cytometric analysis of splenocytes (Workman et al, 2005), T cell hybridomas expressing wild-type or chimeric CD4:murine LAG-3 (Workman et al, 2002) and CD4+ regulatory T cells (Chien et al, 2017). It has also been used in immunoprecipitation analysis of murine T hybridoma 3A9 cells transduced with murine LAG-3 (Li et al, 2004). This antibody blocks LAG-3 function in vitro, inhibiting antigen-induced IL-2 production in LAG-3-expressing T cell hybridomas, but does not block LAG-3:MHC class II interaction (Workman et al, 2002). Treatment with this antibody also blocks LAG-3 function in vivo, leading to accelerated homeostatic expansion of WT T cells (Workman et al, 2005). Administration of this LAG-3-blocking antibody, in combination with PD-L1 blockade, synergistically improves the survival of lymphodepleted myeloma-bearing mice (Jing et al, 2015).

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

    Autre désignation

    Lag3

    Sujet

    CD223, LAG3, Lymphocyte activation gene 3 protein

    UniProt

    Q61790

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!